TCG Crossover GP II, LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-15 4:17 pm Purchase | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | TCG Crossover GP II, LLC | 2,076,357 9.900% | 2,076,357 (New Position) | Filing |